News Headlines Article

As FDA approves ‘pink Viagra’ for women, controversy persists
Los Angeles Times

After clearing the way for Viagra and more than two dozen other treatments to enhance the sex lives of men, the U.S. Food and Drug Administration on Tuesday gave its blessing to the first medication designed to increase sexual desire in women.

The FDA’s approval of flibanserin, often known by the nickname “pink Viagra,” reverses two earlier rejections of the pill as a treatment for hypoactive sexual desire disorder, or HSDD.

Commands